The ASX had a positive end to the week with the ASX 200 gaining 0.87% today taking its weekly gain to 1.9%.

All sectors gained with the best being resources which gained nearly 1.7%.

Australia’s rise was in line with the broader Asia-Pacific region thanks to concerns about a US default easing and China releasing better than expected economic data.

 

TODAY’S BIGGEST SMALL CAP WINNERS

Stocks highlighted in yellow rose after making announcements during the trading day.

Scroll or swipe to reveal table. Click headings to sort.

Rewardle Holdings (ASX:RXH) unveiled a deal that would see it earn equity in BNPL firm SplitPay.

Hannans’ (ASX:HNR)  MoU to commercialise lithium-ion battery recycling technology in Scandinavia is progressing.

Biotech Immuron (ASX:IMC) jumped 19% this morning, after announcing a recent publication of the potential antiviral benefits of its lead drug, IMM-124E.

 

TODAY’S BIGGEST SMALL CAP LOSERS

Stocks highlighted in yellow fell after making announcements during the trading day.

Scroll or swipe to reveal table. Click headings to sort.

Sensera (ASX:SE1) plunged after telling shareholders it was not able to go ahead with its plans to provide rapid COVID testing in volumes that would make it commercially viable.

 

ANNOUNCEMENTS YOU MAY’VE MISSED

Engineering company Korvest (ASX:KOV) released updated profit guidance for FY22. It expects that the first half profit before tax will exceed $8 million as long as there are no further COVID-19 related construction shutdowns.

Elanor (ASX:ENN) announced its Healthcare Real Estate Fund acquired Highpoint Health Hub in Brisbane for $51.9 million. This is the sixth acquisition by the fund and takes the portfolio to over $267 million.

Lumos Diagnostics (ASX:LDX) agreed to withdraw an announcement outlining an economic evaluation of its FebriDx respiratory disease test. The company said it was not intended to constitute a financial forecast of the potential market for FebriDx.

Cynata Therapeutics (ASX:CYP) announced a planned Data Safety Monitoring Board (DSMB) review of Cynata’s MEND clinical trial was completed. The review recommended the trial continue unchanged.

Bardoc Gold (ASX:BDC) announced a 6:1 share consolidation subject to shareholder approval at its 30 November AGM. The company says the proposed consolidation would result in a more appropriate and effective capital structure.

Metcash (ASX:MTS)  CEO Jeff Adams handed in his resignation to the board ending a 4 year tenure. Succeeding him will be Doug Jones, currently the CEO of South African company Massmart Wholesale.

 

TRADING HALTS

Monday
Seafarms Group (ASX:SFG) – project cost update
Alchemy Resources (ASX:ALY) – capital raising
Vanadium Resources (ASX:VR8) – capital raising
New Talisman Gold Mines (ASX:NTL) – rights issue update

Tuesday

Recce Pharmaceuticals (ASX:RCE) – cleansing notice correction
Suvo Strategic Minerals (ASX:SUV) – mineral resource estimate
4DS Memory (ASX:4DS) – technical update
Resource Mining Corporation (ASX:RMI) – disposal of sale shares
Antilles Gold (ASX:AAU) – capital raising
Nova Minerals (ASX:NVA) – drill results